A new hope; the M. tuberculosis strikes back

Tyler D. Bold

doi:10.1016/j.chom.2023.02.004

A new hope; the M. tuberculosis strikes back

Tyler D. Bold

Medicine - Infectious Disease and International

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The development of new tools to combat TB is counterbalanced by the discovery of previously unknown biological mechanisms used by M. tuberculosis to evade eradication. Two new studies offer both new hope, in a promising ribosome-targeting TB therapy, as well as a new challenge to overcome, in antibiotic resilience.

Original language	English (US)
Pages (from-to)	321-322
Number of pages	2
Journal	Cell Host and Microbe
Volume	31
Issue number	3
DOIs	https://doi.org/10.1016/j.chom.2023.02.004
State	Published - Mar 8 2023

Bibliographical note

Publisher Copyright:
© 2023 Elsevier Inc.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.chom.2023.02.004

OpenUrl availability

Full text

Cite this

@article{f0cae924883443b49b4c5f9058fc9765,

title = "A new hope; the M. tuberculosis strikes back",

abstract = "The development of new tools to combat TB is counterbalanced by the discovery of previously unknown biological mechanisms used by M. tuberculosis to evade eradication. Two new studies offer both new hope, in a promising ribosome-targeting TB therapy, as well as a new challenge to overcome, in antibiotic resilience.",

author = "Bold, {Tyler D.}",

note = "Publisher Copyright: {\textcopyright} 2023 Elsevier Inc.",

year = "2023",

month = mar,

day = "8",

doi = "10.1016/j.chom.2023.02.004",

language = "English (US)",

volume = "31",

pages = "321--322",

journal = "Cell Host and Microbe",

issn = "1931-3128",

publisher = "Cell Press",

number = "3",

}

TY - JOUR

T1 - A new hope; the M. tuberculosis strikes back

AU - Bold, Tyler D.

PY - 2023/3/8

Y1 - 2023/3/8

N2 - The development of new tools to combat TB is counterbalanced by the discovery of previously unknown biological mechanisms used by M. tuberculosis to evade eradication. Two new studies offer both new hope, in a promising ribosome-targeting TB therapy, as well as a new challenge to overcome, in antibiotic resilience.

AB - The development of new tools to combat TB is counterbalanced by the discovery of previously unknown biological mechanisms used by M. tuberculosis to evade eradication. Two new studies offer both new hope, in a promising ribosome-targeting TB therapy, as well as a new challenge to overcome, in antibiotic resilience.

UR - http://www.scopus.com/inward/record.url?scp=85149706892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85149706892&partnerID=8YFLogxK

U2 - 10.1016/j.chom.2023.02.004

DO - 10.1016/j.chom.2023.02.004

M3 - Comment/debate

C2 - 36893727

AN - SCOPUS:85149706892

SN - 1931-3128

VL - 31

SP - 321

EP - 322

JO - Cell Host and Microbe

JF - Cell Host and Microbe

IS - 3

ER -

A new hope; the M. tuberculosis strikes back

Abstract

Bibliographical note

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this